International Chair on Cardiometabolic Risk

CMR Short Reviews
- The Concept of CMR
  Historical background on global cardiometabolic risk, epidemiological aspects of obesity and type 2 diabetes, ABCs of cardiovascular disease risk factors, intra-abdominal adiposity, metabolic syndrome and contribution to cardiometabolic risk.
- Evaluating CMR
  Research and clinical tools to identify individuals with excess intra-abdominal adiposity and quantify their risk of diabetes and cardiovascular disease (global cardiometabolic risk).
- Managing CMR
  Notions and practical tools to better manage the abdominally obese patient with excess intra-abdominal adiposity and related clustering abnormalities.
Documentation Centre
- Slides, videos and more

Date	Categories	Title	Author	Format
July 02, 2010	Lipids/Lipoproteins Cardiovascular Disease	Why do elevated HDL cholesterol concentrations not protect against cardiovascular disease?	Arnold von Eckardstein, MD Institute of Clinical Chemistry, University Hospital of Zurich and Center for Integrative Human Biology, University of Zurich, Zurich, Switzerland	Expert Opinions Video 1:40 min. (8 MB)
June 11, 2010	Cardiovascular Disease Lipids/Lipoproteins	What are the best therapeutic options to improve HDL functions?	Arnold von Eckardstein, MD Institute of Clinical Chemistry, University Hospital of Zurich and Center for Integrative Human Biology, University of Zurich, Zurich, Switzerland	Expert Opinions Video 1:08 min. (6 MB)
May 21, 2010	Cardiovascular Disease Lipids/Lipoproteins	What is the relationship between HDL and the endothelium?	Arnold von Eckardstein, MD Institute of Clinical Chemistry, University Hospital of Zurich and Center for Integrative Human Biology, University of Zurich, Zurich, Switzerland	Expert Opinions Video 1:12 min. (6 MB)
March 12, 2010	Lipids/Lipoproteins Cardiovascular Disease	Could you summarize the protective roles of HDL particles? Do high HDL levels confer greater protection?	Arnold von Eckardstein, MD Institute of Clinical Chemistry, University Hospital of Zurich and Center for Integrative Human Biology, University of Zurich, Zurich, Switzerland	Expert Opinions Video 1:19 min. (5 MB)
December 18, 2009	Diabetes Lipids/Lipoproteins Cardiovascular Disease	Could there be a link between HDL and diabetes?	Arnold von Eckardstein, MD Institute of Clinical Chemistry, University Hospital of Zurich and Center for Integrative Human Biology, University of Zurich, Zurich, Switzerland	Expert Opinions Video 1:23 min. (5 MB)
October 16, 2009	Diabetes Cardiovascular Disease	Could you comment on the heterogeneity of risk in type 2 diabetic patients?	Arnold von Eckardstein, MD Institute of Clinical Chemistry, University Hospital of Zurich and Center for Integrative Human Biology, University of Zurich, Zurich, Switzerland	Expert Opinions Video 1:03 min. (4 MB)

The content of this website is provided for educational and informational purposes only and is not to be used for medical advice, diagnosis or treatment. Use of this site is subject to the terms and conditions contained in our Legal Notices.

Documentation Centre